PubMed Health⌕ Search

PubMed · 10356608

[Inverse radiotherapy planning].

Abstract

BACKGROUND: In clinical practice it sometimes happens that with currently available conformal radiotherapy techniques no satisfactory dose distribution can be achieved. In these cases inverse radiotherapy planning and intensity modulated radiotherapy may give better solutions. METHOD: Inverse planning is a technique using a computer program to automatically achieve a treatment plan which has an optimal merit. This merit may either depend on dose or dose-volume constraints like minimum and maximum doses in the target region or critical organs, respectively, or biological indices like the complication free tumor control rate. As the result of inverse planning the inhomogeneous intensity fluence of the beams is calculated. These fluence distributions may be generated by beam compensators or multi-leaf collimation. RESULTS: Clinical studies to prove the advantage of inverse planning are already on the way. It has been shown that this technology is safe and that the dose distributions which can be achieved are superior to conventional methods. CONCLUSIONS: Inverse treatment planning and intensity modulated radiation therapy will almost certainly come to be the technique of choice for selected clinical cases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W Schlegel, P Kneschaurek. 1999. [Inverse radiotherapy planning].. https://doi.org/10.1007/bf02742396

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Hematometrocolpos in an adolescent female treated for pelvic Ewing sarcoma.

Radiation therapy is often used to achieve local control of pelvic Ewing sarcoma in children. The effects of radiation on the female reproductive tract have been well documented in adults with gynecological malignancies, but the long-term consequences of pelvic radiation in pre-pubertal or adolescent girls are not as well described. We report a case of hematometrocolpos developing in an adolescent previously treated with chemotherapy and radiation therapy for pelvic Ewing sarcoma. We describe the clinical presentation, radiographic features, gross pathology, treatment strategies, outcome, as well as putative predisposing factors and preventative interventions.

Bone Neoplasms↗

Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer.

BACKGROUND: Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. Kallikrein 4 (KLK4/hK4) is expressed in both PCa and mineralized tissues. We determined if KLK4/hK4 expression was associated with, and influenced by, the bone environment of metastatic PCa. METHODS: Immunohistochemistry, in vitro co-culture, cell migration, and attachment assays. RESULTS: hK4 was localized to tumor cells and osteoblasts in bone metastases. KLK4/hK4 increased in LNCaP and PC3 cells co-cultured with SaOs2 cells; SaOs2 KLK4/hK4 was unchanged. Co-culture did not affect cell proliferation but altered alkaline phosphatase activity/mRNA levels in SaOs2 cells. KLK4-transfected PC3 cells had increased migration towards SaOs2 conditioned medium and greater attachment to the bone-matrix proteins, collagens I and IV. CONCLUSIONS: hK4 expression and interaction with both tumor cells and osteoblasts suggests a role for hK4 in PCa bone metastasis. Whether this observation is unique to bone metastasis or reflects a role for hK4 in PCa metastasis generally is yet to be established.

Bone Neoplasms↗